BLS Pharmaceuticals Limited (ASX:BLS)

BLS Pharmaceuticals Revenue

BLS Pharmaceuticals had revenue of 31.15M AUD in the half year ending December 31, 2025, with 538.22% growth. This brings the company's revenue in the last twelve months to 47.95M, up 178.15% year-over-year. In the fiscal year ending June 30, 2025, BLS Pharmaceuticals had annual revenue of 29.28M with 203.66% growth.

• Revenue (ttm): 47.95M
• Revenue Growth: +178.15%
• P/S Ratio: 4.27
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 204.68M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	29.28M	19.64M	203.66%
Jun 30, 2024	9.64M	4.34M	81.98%
Jun 30, 2023	5.30M	4.84M	1,042.88%
Jun 30, 2022	463.64K	-1.74M	-78.97%
Jun 30, 2021	2.20M	-130.94K	-5.61%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 17, 2026

Data Sources Report a data error